⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adult giant cell glioblastoma

Every month we try and update this database with for adult giant cell glioblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pazopanib in Treating Patients With Recurrent GlioblastomaNCT00459381
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
pazopanib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT02337426
Adult Brain Gli...
Adult Giant Cel...
Adult Gliosarco...
Dimethyl Fumara...
Temozolomide
Radiation Thera...
18 Years - Virginia Commonwealth University
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant GliomaNCT00516282
Brain and Centr...
CLORETAZINE
temozolomide
18 Years - Northwestern University
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the BrainNCT00039572
Brain and Centr...
Melanoma (Skin)
Metastatic Canc...
boronophenylala...
18 Years - National Cancer Institute (NCI)
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma MultiformeNCT00482677
Brain and Centr...
temozolomide
DNA methylation...
quality-of-life...
Radiation
65 Years - 120 YearsCanadian Cancer Trials Group
Dovitinib in Treating Patients With Recurrent or Progressive GlioblastomaNCT01753713
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
dovitinib
laboratory biom...
18 Years - Case Comprehensive Cancer Center
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsNCT00499798
Brain and Centr...
Chemotherapeuti...
Infertility
18 Years - 60 YearsWake Forest University Health Sciences
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaNCT00423735
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
Dasatinib
Pharmacological...
18 Years - National Cancer Institute (NCI)
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00770471
Brain and Centr...
temozolomide
veliparib
DNA methylation...
gene expression...
mutation analys...
proteomic profi...
high performanc...
immunoenzyme te...
laboratory biom...
mass spectromet...
pharmacogenomic...
pharmacological...
adjuvant therap...
radiation thera...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00099125
Brain and Centr...
irinotecan hydr...
temozolomide
adjuvant therap...
radiation thera...
18 Years - Radiation Therapy Oncology Group
Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma MultiformeNCT00005813
Brain and Centr...
bispecific anti...
lymphokine-acti...
conventional su...
18 Years - Dartmouth-Hitchcock Medical Center
Suramin in Treating Patients With Recurrent Primary Brain TumorsNCT00002639
Brain and Centr...
chemotherapy
suramin
15 Years - National Cancer Institute (NCI)
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaNCT00005951
Brain and Centr...
irinotecan hydr...
temozolomide
18 Years - Duke University
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00047294
Brain and Centr...
celecoxib
temozolomide
thalidomide
adjuvant therap...
18 Years - 120 YearsDana-Farber Cancer Institute
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00047294
Brain and Centr...
celecoxib
temozolomide
thalidomide
adjuvant therap...
18 Years - 120 YearsDana-Farber Cancer Institute
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaNCT01103375
Adult Anaplasti...
Adult Anaplasti...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Oligodend...
Recurrent Adult...
erlotinib hydro...
isotretinoin
laboratory biom...
protein express...
18 Years - Wake Forest University Health Sciences
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaNCT00662506
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Cediranib Malea...
Diffusion Tenso...
Diffusion Weigh...
Dynamic Contras...
Fludeoxyglucose...
Intensity-Modul...
Laboratory Biom...
Perfusion Magne...
Positron Emissi...
Temozolomide
18 Years - National Cancer Institute (NCI)
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsNCT00008086
Brain and Centr...
Unspecified Adu...
calcitriol
carboplatin
18 Years - University of Pittsburgh
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary GlioblastomaNCT01310868
Glioblastoma
5-ALA
Gliadel wafers
Radiotherapy as...
Concomitant che...
Adjuvant chemot...
18 Years - University College, London
Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma MultiformeNCT00021307
Brain and Centr...
carboplatin
temozolomide
18 Years - Fox Chase Cancer Center
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain TumorsNCT00039494
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
erlotinib hydro...
3-dimensional c...
temozolomide
18 Years - National Cancer Institute (NCI)
Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma MultiformeNCT00005813
Brain and Centr...
bispecific anti...
lymphokine-acti...
conventional su...
18 Years - Dartmouth-Hitchcock Medical Center
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeNCT00895180
Adult Glioblast...
olaratumab
ramucirumab
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00274833
CNS Tumor, Adul...
erlotinib hydro...
temozolomide
radiation thera...
18 Years - Case Comprehensive Cancer Center
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsNCT00002647
Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 YearsNational Cancer Institute (NCI)
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaNCT00036972
Brain and Centr...
cintredekin bes...
adjuvant therap...
conventional su...
neoadjuvant the...
18 Years - National Cancer Institute (NCI)
AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma MultiformeNCT00107237
Brain and Centr...
AEE788
everolimus
18 Years - Novartis
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideNCT00369590
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Gliosarco...
Recurrent Adult...
ziv-aflibercept
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma MultiformeNCT00004262
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
conventional su...
3-dimensional c...
stereotactic ra...
motexafin gadol...
magnetic resona...
spectroscopy
18 Years - National Cancer Institute (NCI)
Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00003409
Brain and Centr...
motexafin gadol...
radiation thera...
18 Years - National Cancer Institute (NCI)
Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00014170
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
gefitinib
pharmacological...
laboratory biom...
questionnaire a...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaNCT00008008
Brain and Centr...
filgrastim
sargramostim
cyclophosphamid...
thiotepa
autologous bone...
bone marrow abl...
peripheral bloo...
- National Cancer Institute (NCI)
Sirolimus in Treating Patients With Glioblastoma MultiformeNCT00047073
Brain and Centr...
Rapamycin
Surgery
Supportive Care
18 Years - 120 YearsJonsson Comprehensive Cancer Center
Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma MultiformeNCT00010036
Brain and Centr...
carboplatin
irinotecan hydr...
radiation thera...
18 Years - NYU Langone Health
Bevacizumab in Recurrent Grade II and III GliomaNCT01164189
Central Nervous...
Bevacizumab
Temozolomide
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Vaccine Therapy in Treating Patients With Malignant GliomaNCT00612001
Brain and Centr...
glioma-associat...
18 Years - Jonsson Comprehensive Cancer Center
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerNCT00025558
Brain and Centr...
filgrastim
carboplatin
temozolomide
thiotepa
autologous bone...
peripheral bloo...
1 Year - 49 YearsNYU Langone Health
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00486603
Brain and Centr...
hydroxychloroqu...
temozolomide
pharmacological...
Radiation
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsNCT00005083
Brain and Centr...
conventional su...
magnetic resona...
magnetic resona...
18 Years - 55 YearsJonsson Comprehensive Cancer Center
Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT02227901
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Tipifarnib
External Beam R...
Temozolomide
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaNCT00401024
Brain and Centr...
imatinib mesyla...
pharmacological...
conventional su...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaNCT00087061
Brain and Centr...
gimatecan
18 Years - National Cancer Institute (NCI)
Procarbazine in Treating Patients With Recurrent Brain TumorNCT00004004
Brain and Centr...
procarbazine hy...
18 Years - National Cancer Institute (NCI)
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeNCT00002545
Brain and Centr...
carmustine
low-LET photon ...
18 Years - Radiation Therapy Oncology Group
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain TumorsNCT00003461
Brain and Centr...
Metastatic Canc...
Neuroblastoma
surgical proced...
astatine At 211...
18 Years - Duke University
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant GliomaNCT00352313
Brain and Centr...
ATN-161
carboplatin
18 Years - National Institutes of Health Clinical Center (CC)
Olaparib and Temozolomide in Treating Patients With Relapsed GlioblastomaNCT01390571
Brain and Centr...
olaparib
temozolomide
gene expression...
protein express...
laboratory biom...
pharmacological...
diffusion-weigh...
dynamic contras...
therapeutic con...
18 Years - Cancer Research UK
Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBMNCT00004146
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
radiation thera...
carboxyamidotri...
pharmacological...
18 Years - National Cancer Institute (NCI)
Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma MultiformeNCT00006386
Brain and Centr...
carmustine
radiation thera...
stereotactic ra...
- Radiation Therapy Oncology Group
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaNCT00756106
Brain and Centr...
temozolomide
Imaging biomark...
Photon Radiatio...
18 Years - Massachusetts General Hospital
Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma MultiformeNCT00010036
Brain and Centr...
carboplatin
irinotecan hydr...
radiation thera...
18 Years - NYU Langone Health
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaNCT00010049
Brain and Centr...
imatinib mesyla...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeNCT00028678
Brain and Centr...
dalteparin
radiation thera...
18 Years - 120 YearsEastern Cooperative Oncology Group
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation TherapyNCT00436436
Brain and Centr...
O6-benzylguanin...
temozolomide
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorNCT00070161
Brain and Centr...
Radiation Toxic...
EGb761
donepezil hydro...
cognitive asses...
18 Years - 120 YearsWake Forest University Health Sciences
Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by SurgeryNCT00814593
Brain and Centr...
lymphokine-acti...
polifeprosan 20...
18 Years - Lisata Therapeutics, Inc.
Karenitecin in Treating Patients With Recurrent Malignant GliomaNCT00014521
Brain and Centr...
karenitecin
18 Years - National Cancer Institute (NCI)
Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma MultiformeNCT00004937
Brain and Centr...
acridine carbox...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaNCT01013285
Brain and Centr...
bevacizumab
temozolomide
external beam r...
18 Years - Jonsson Comprehensive Cancer Center
EMD 121974 in Treating Patients With Progressive or Recurrent GliomaNCT00006093
Brain and Centr...
cilengitide
18 Years - National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Progressive or Recurrent Brain TumorsNCT00012038
Brain and Centr...
irofulven
18 Years - National Cancer Institute (NCI)
Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma MultiformeNCT00004937
Brain and Centr...
acridine carbox...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant AstrocytomaNCT00003842
Brain and Centr...
interleukin-4 P...
isolated perfus...
surgical proced...
18 Years - National Cancer Institute (NCI)
Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaNCT00305864
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
3-Dimensional C...
Motexafin Gadol...
Temozolomide
18 Years - National Cancer Institute (NCI)
Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00005856
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
oxaliplatin
pharmacological...
18 Years - National Cancer Institute (NCI)
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00390403
Brain and Centr...
R-(-)-gossypol ...
temozolomide
gene expression...
mutation analys...
protein express...
laboratory biom...
pharmacological...
adjuvant therap...
radiation thera...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorNCT00006358
Brain and Centr...
temozolomide
thalidomide
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaNCT00005082
Brain and Centr...
biopsy
magnetic resona...
18 Years - Jonsson Comprehensive Cancer Center
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During SurgeryNCT00004015
Brain and Centr...
sodium borocapt...
adjuvant therap...
50 Years - European Organisation for Research and Treatment of Cancer - EORTC
Carmustine in Treating Patients With Recurrent Malignant GliomaNCT00004028
Brain and Centr...
carmustine
conventional su...
18 Years - National Cancer Institute (NCI)
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent GlioblastomaNCT01730950
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
bevacizumab
radiation thera...
18 Years - Radiation Therapy Oncology Group
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma MultiformeNCT00915694
Brain and Centr...
nelfinavir mesy...
temozolomide
adjuvant therap...
radiation thera...
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma MultiformeNCT01575275
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
aminolevulinic ...
therapeutic con...
18 Years - Case Comprehensive Cancer Center
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaNCT01013285
Brain and Centr...
bevacizumab
temozolomide
external beam r...
18 Years - Jonsson Comprehensive Cancer Center
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant GliomaNCT00897611
High Grade Glio...
DNA methylation...
polymerase chai...
computed tomogr...
magnetic resona...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Monoclonal Antibody Therapy in Treating Patients With Recurrent GliomasNCT00002753
Brain and Centr...
iodine I 131 mo...
3 Years - Duke University
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant GliomaNCT00301873
Brain Tumors
Osteoporosis
Central Nervous...
IV Zometa
18 Years - Duke University
Biological Therapy in Treating Patients With Primary or Advanced GliomaNCT00003067
Brain and Centr...
aldesleukin
lymphokine-acti...
18 Years - National Cancer Institute (NCI)
Biological Therapy in Treating Patients With Primary or Advanced GliomaNCT00003067
Brain and Centr...
aldesleukin
lymphokine-acti...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: